
AgeX Therapeutics AGE
AgeX Therapeutics ROE | AGE
ROE Jährlich AgeX Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51843.24 | -1738.07 | -16.32 | 60.78 | 73.32 | -39.09 | -464.42 | -91.14 | - | 66.15 | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 51843.24 | -1738.07 | 5521.61 |
ROE Vierteljährlich AgeX Therapeutics
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8972.39 | 8735.21 | 8384.05 | 8114.67 | -1540.92 | -1257.14 | -890.04 | -528.42 | 7.7 | 12.64 | 42.09 | -15.39 | 9.5 | 30.84 | 52.87 | 34.11 | -5.7 | -2.18 | 7.92 | -1.38 | -27.83 | 21.05 | 119.91 | 1011.75 | 951.63 | 816.87 | 645.57 | -354.88 | -279.03 | -238.65 | -199.21 | -57.96 | -28.88 | -25.92 | -3.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8972.39 | -1540.92 | 928.97 |
ROE anderer Aktien in der Pharmaeinzelhändler
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Brainstorm Cell Therapeutics
BCLI
|
103.22 | - | -2.5 % | $ 5.88 M | ||
|
BeiGene, Ltd.
BGNE
|
6.58 | - | 0.49 % | $ 251 B | ||
|
EyePoint Pharmaceuticals
EYPT
|
-75.78 | $ 0.23 | -12.11 % | $ 16.8 K | ||
|
Bio-Path Holdings
BPTH
|
-6424.68 | - | - | $ 100 K | ||
|
Cara Therapeutics
CARA
|
-86.94 | - | -3.03 % | $ 260 M | ||
|
ChromaDex Corporation
CDXC
|
22.71 | - | -0.88 % | $ 598 M | ||
|
Caladrius Biosciences
CLBS
|
-114.44 | - | -16.75 % | $ 25.8 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
-5.66 | - | -5.98 % | $ 34.1 M | ||
|
Diffusion Pharmaceuticals
DFFN
|
-148.0 | - | 11.68 % | $ 8.97 M | ||
|
Eloxx Pharmaceuticals
ELOX
|
49.5 | - | -5.68 % | $ 8.28 M | ||
|
Enochian Biosciences
ENOB
|
39.47 | - | - | $ 40.5 M | ||
|
Esperion Therapeutics
ESPR
|
7.51 | - | - | $ 661 M | ||
|
Evofem Biosciences
EVFM
|
-0.53 | - | 7.55 % | $ 38.1 M | ||
|
Eyenovia
EYEN
|
-110.36 | - | 49.81 % | $ 13.2 M | ||
|
FibroGen
FGEN
|
-610.73 | - | - | $ 889 M | ||
|
Homology Medicines
FIXX
|
70.93 | - | 0.77 % | $ 53.4 M | ||
|
Amicus Therapeutics
FOLD
|
-9.89 | - | - | $ 4.47 B | ||
|
Frequency Therapeutics
FREQ
|
-227.96 | - | - | $ 528 M | ||
|
Galecto
GLTO
|
-87.29 | - | - | $ 762 M | ||
|
GlycoMimetics
GLYC
|
0.08 | - | 9357.83 % | $ 1.01 B | ||
|
Graybug Vision
GRAY
|
445.11 | - | -11.23 % | $ 9.65 M | ||
|
Galera Therapeutics
GRTX
|
3750.6 | - | -32.59 % | $ 7.61 M | ||
|
Happiness Biotech Group Limited
HAPP
|
-40.75 | - | 1.35 % | $ 17.8 M | ||
|
Novavax
NVAX
|
-344.65 | $ 7.47 | -3.24 % | $ 1.21 B | ||
|
Hepion Pharmaceuticals
HEPA
|
-310.32 | - | -18.79 % | $ 39.3 K | ||
|
Hoth Therapeutics
HOTH
|
-202.73 | - | - | $ 18.8 M | ||
|
IMARA
IMRA
|
-22.56 | - | 15.96 % | $ 663 M | ||
|
KalVista Pharmaceuticals
KALV
|
4039.1 | - | - | $ 1.45 B | ||
|
KemPharm
KMPH
|
53.82 | - | -0.34 % | $ 200 M | ||
|
Kezar Life Sciences
KZR
|
-79.96 | - | - | $ 53.3 M | ||
|
Lixte Biotechnology Holdings
LIXT
|
-62.9 | - | - | $ 63.4 M | ||
|
Magenta Therapeutics
MGTA
|
-32.9 | - | -7.74 % | $ 41.6 M | ||
|
NovaBay Pharmaceuticals
NBY
|
99.84 | - | - | $ 11.3 M | ||
|
NeuroBo Pharmaceuticals
NRBO
|
-243.26 | - | 0.43 % | $ 12 M | ||
|
OncoCyte Corporation
OCX
|
0.16 | - | 17.22 % | $ 355 K | ||
|
Onconova Therapeutics
ONTX
|
-1457.87 | - | -0.47 % | $ 21 M | ||
|
Opthea Limited
OPT
|
80.96 | - | - | $ 1.2 B | ||
|
Verastem
VSTM
|
-366.23 | $ 6.33 | -7.8 % | $ 439 M | ||
|
BiomX
PHGE
|
2780.26 | $ 1.85 | 14.2 % | $ 3.02 M | ||
|
Pieris Pharmaceuticals
PIRS
|
-149.07 | - | -15.58 % | $ 1.22 B | ||
|
Plus Therapeutics
PSTV
|
-560.21 | - | - | $ 301 M | ||
|
Pluristem Therapeutics
PSTI
|
103.41 | - | -1.9 % | $ 33.3 M | ||
|
Qualigen Therapeutics
QLGN
|
-60.7 | - | 5.59 % | $ 1.16 M | ||
|
Qilian International Holding Group Limited
QLI
|
-5.1 | - | -6.08 % | $ 184 M | ||
|
Cassava Sciences
SAVA
|
-122.27 | - | - | $ 110 M | ||
|
Selecta Biosciences
SELB
|
103.22 | - | -8.69 % | $ 126 M | ||
|
Sangamo Therapeutics
SGMO
|
861.59 | - | - | $ 50.4 M | ||
|
Salarius Pharmaceuticals
SLRX
|
-212.58 | - | - | $ 2.64 M | ||
|
Sensei Biotherapeutics
SNSE
|
-113.41 | - | - | $ 17.5 M | ||
|
Sonnet BioTherapeutics Holdings
SONN
|
-148.43 | - | - | $ 826 K |